Reclassification of the Etiology of Infant Mortality With Whole-Genome Sequencing is a research paper published in JAMA Network Open (2023). On theSindex it has a DataRank of 1.2. It has been cited 45 times, with 36 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.574
From this paper's citation signal
Citation Network Contribution
0.645
From 23 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 36 citers.
NICHD NIH HHS
Grant: K12 HD105271
NHLBI NIH HHS
Grant: R25 HL145817
NHLBI NIH HHS
Grant: T32 HL007444
National Institutes of Health
Grant: 5R01HL145175-04
Oligogenic Models of Cardiomyopathy
National Institutes of Health
Grant: 5R01HD101540-05
Genomic and Environmental Determinants of Infant Deaths in San Diego County in 2015-2022
FWCI
10.60
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 2 of Validated WGS and WES protocols proved saliva-derived gDNA as an equivalent to blood-derived gDNA for clinical and population genomic analyses
Additional file 2 of Validated WGS and WES protocols proved saliva-derived gDNA as an equivalent to blood-derived gDNA for clinical and population genomic analyses
Additional file 1 of Validated WGS and WES protocols proved saliva-derived gDNA as an equivalent to blood-derived gDNA for clinical and population genomic analyses
Additional file 1 of Validated WGS and WES protocols proved saliva-derived gDNA as an equivalent to blood-derived gDNA for clinical and population genomic analyses